Evidence map›Paper›PMID 25728323›Full record

ArticleVaccine2015

Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.

Jennifer Serwanga, Ritah Nakiboneka, Susan Mugaba, Brian Magambo, Nicaise Ndembi, Frances Gotch, Pontiano Kaleebu

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jennifer SerwangaMRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda. Electronic address: jennifer.serwanga@mrcuganda.org.
Ritah NakibonekaMRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Susan MugabaMRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Brian MagamboMRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Nicaise NdembiMRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Frances GotchDepartment of Immunology, Imperial College, Chelsea & Westminster Hospital, London, United Kingdom.
Pontiano KaleebuMRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, United Kingdom.
Uganda Virus Research Institute · UGChelsea and Westminster Hospital · GBLondon School of Hygiene & Tropical Medicine · GB

Funding

Wellcome TrustWellcome Trust 087540
6 · The paper itself

Abstract

OBJECTIVE(S): We evaluated relationships between critical Gag T-cell escape mutations and concomitant T-cell responses to determine whether HLA-restricted Gag mutations that confer protection, occur at similar rates in a population infected with mixed HIV-1 clades A1 and D viruses.

methodsAssessment of Gag selective pressure, and adaptive T-cell functions to KAFSPEVIPMF (KF11), ISPRTLNAW (ISW9) and TSTLQEQIGW (TW10) Gag epitopes were combined with host HLA to assess correlations with rates of critical epitope escape mutations in clades A1- (n=23) and D- (n=21) infected, untreated subjects. Infecting clades and selection pressure were determined from the gag sequences.

resultsOverall, Gag escape mutations A163X in KF11 were detected in 61% (14/23) A1- infected compared to 5% (1/21) in D-infected subjects (p=0.00015). Gag mutations I147X in the ISW9 epitope were seen in 43%: (10/23) clade A compared to 5%: (1/21) clade D infected subjects, p=0.007, Fisher's Exact test. Both mutations were more frequent in clade A1 infection. Frequencies of the measured epitope-specific T-cell responses were comparable across clades. Peptide binding affinities for the restricting HLA alleles did not differ across clades. Overall, selection pressure on the Gag protein was significantly greater in clade A than in clade D sequences.

conclusionsThese findings imply that HIV-1 vaccine strategies designed to target structurally constrained T-cell epitopes may be further challenged by clade-driven outcomes in specific HLA-restricted Gag epitopes. Equally, the data are line with slower HIV-1 disease progression in clade A infection; and raise hope that increased selective pressure on Gag may be protective irrespective of host HLA alleles.

Indexed as

Genes, MHC Class IAdultAIDS VaccinesAllelesBlack PeopleChronic DiseaseCytokinesEpitopes, T-LymphocyteFlow Cytometrygag Gene Products, Human Immunodeficiency VirusHIV-1HIV InfectionsHLA-B AntigensHumansInterferon-gammaMaleAIDS VaccinesCytokinesEpitopes, T-Lymphocytegag Gene Products, Human Immunodeficiency VirusHLA-B AntigensInterferon-gammaClades A1 and DEscape mutationsGagHIV-1HLA B allelesSelection pressure

Identifiers

PMID25728323
PMCPMC4374673
OpenAlexW2067290334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.